Tech Company Financing Transactions

Prevail Therapeutics Funding Round

On 3/9/2018, Prevail Therapeutics landed $75 million in Series A investment from Adage Capital Management, Alexandria Venture Investments and Boxer Capital.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

430 East 29th St. 1520
New York, NY 10016
USA

Phone

917-336-9310

Website

www.prevailtherapeutics.com

Email Address

[email protected]

Overview

Prevail Therapeutics is a biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease. Prevail is establishing a pipeline of programs that includes discovery-phase and preclinical development efforts.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Asa Abeliovich

        

Chief Financial Officer

Brett Kaplan

        

Chief Medical Officer

Jeffrey Sevigny

        

Chief Technical Officer

Yong Dai

        

VP - Bus. Development

Franz Hefti

        

VP - Bus. Development

Emily Minkow

        

VP - General Counsel

Kira Schwartz

        

Browse more venture capital transactions:

Prev: 3/9/2018: Mojio venture capital transaction
Next: 3/9/2018: Zebi venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary